Weighted Average Number of Shares Outstanding, Basic of Silo Pharma, Inc. from 31 Dec 2011 to 30 Sep 2025

Taxonomy & unit: us-gaap: shares
Description: Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary: Silo Pharma, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Dec 2011 to 30 Sep 2025.
Silo Pharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 9,331,346, a 117% increase year-over-year.
Silo Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 3,680,389, a 19% increase from 2023.
Silo Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 3,079,874, a 35% increase from 2022.
Silo Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 2,284,240, a 20% increase from 2021.
Source SEC data: View on sec.gov

Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)

Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)

Weighted Average Number of Shares Outstanding, Basic, Annual (shares)

Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Silo Pharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	9,331,346	+5,029,499	+117%	01 Jul 2025	30 Sep 2025	10-Q	13 Nov 2025	2025	Q3
Q2 2025	6,279,733	+3,227,067	+106%	01 Apr 2025	30 Jun 2025	10-Q	13 Aug 2025	2025	Q2
Q1 2025	4,484,456	+1,617,522	+56%	01 Jan 2025	31 Mar 2025	10-Q	09 May 2025	2025	Q1
Q4 2024	3,680,389	+600,515	+19%	01 Oct 2024	31 Dec 2024	10-K	28 Mar 2025	2024	FY
Q3 2024	4,301,847	+1,193,050	+38%	01 Jul 2024	30 Sep 2024	10-Q	13 Nov 2025	2025	Q3
Q2 2024	3,052,666	-101,186	-3.2%	01 Apr 2024	30 Jun 2024	10-Q	13 Aug 2025	2025	Q2
Q1 2024	2,866,934	-291,863	-9.2%	01 Jan 2024	31 Mar 2024	10-Q	09 May 2025	2025	Q1
Q4 2023	3,079,874	+795,634	+35%	01 Oct 2023	31 Dec 2023	10-K	28 Mar 2025	2024	FY
Q3 2023	3,108,797	+1,108,097	+55%	01 Jul 2023	30 Sep 2023	10-Q	12 Nov 2024	2024	Q3
Q2 2023	3,153,852	+1,165,946	+59%	01 Apr 2023	30 Jun 2023	10-Q	13 Aug 2024	2024	Q2
Q1 2023	3,158,797	+1,186,058	+60%	01 Jan 2023	31 Mar 2023	10-Q	13 May 2024	2024	Q1
Q4 2022	2,284,240			01 Oct 2022	31 Dec 2022	10-K	25 Mar 2024	2023	FY
Q3 2022	2,000,700	+27,961	+1.4%	01 Jul 2022	30 Sep 2022	10-Q	13 Nov 2023	2023	Q3
Q2 2022	1,987,906			01 Apr 2022	30 Jun 2022	10-Q	11 Aug 2023	2023	Q2
Q1 2022	1,972,739			01 Jan 2022	31 Mar 2022	10-Q	12 May 2023	2023	Q1
Q3 2021	1,972,739	-82,443,942	-98%	01 Jul 2021	30 Sep 2021	10-Q	10 Nov 2022	2022	Q3
Q3 2020	84,416,681			01 Jul 2020	30 Sep 2020	10-Q	10 Nov 2021	2021	Q3

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2024	3,680,389	+600,515	+19%	01 Jan 2024	31 Dec 2024	10-K	28 Mar 2025	2024	FY
2023	3,079,874	+795,634	+35%	01 Jan 2023	31 Dec 2023	10-K	28 Mar 2025	2024	FY
2022	2,284,240	+386,925	+20%	01 Jan 2022	31 Dec 2022	10-K	25 Mar 2024	2023	FY
2021	1,897,315	-64,057,376	-97%	01 Jan 2021	31 Dec 2021	10-K	24 Mar 2023	2022	FY
2020	65,954,691			01 Jan 2020	31 Dec 2020	10-K	28 Mar 2022	2021	FY
2013	32,436,953	+1,805,753	+5.9%	01 Jan 2013	31 Dec 2013	10-K	31 Mar 2014	2013	FY
2012	30,631,200	0	0%	01 Jan 2012	31 Dec 2012	10-K	31 Mar 2014	2013	FY
2011	30,631,200			01 Jan 2011	31 Dec 2011	10-K	31 Mar 2014	2013	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.